Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Handfield

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
American Health & Drug Benefits|July 4, 2014
Insurance companies' perspectives on the orphan drug pipelineRobert Handfield, Josh Feldstein
Healthcare (Basel, Switzerland)|February 11, 2023
Evaluating State-Level Prescription Drug Monitoring Program (PDMP) and Pill Mill Effects on Opioid Consumption in Pharmaceutical Supply ChainAmirreza Sahebi-Fakhrabad, Amir Hossein Sadeghi, Robert Handfield
Healthcare (Basel, Switzerland)|July 13, 2024
Exploring Opioid Prescription Patterns and Overdose Rates in South Carolina (2017-2021): Insights into Rising Deaths in High-Risk AreasAmirreza Sahebi-Fakhrabad, Amir Hossein Sadeghi, Eda Kemahlioglu-Ziya, et al.
The Milbank Quarterly|November 2, 2020
A Commons for a Supply Chain in the Post-COVID-19 Era: The Case for a Reformed Strategic National StockpileRobert Handfield, Daniel Joseph Finkenstadt, Eugene S Schneller, et al.
Healthcare (Basel, Switzerland)|April 28, 2023
The Impact of Opioid Prescribing Limits on Drug Usage in South Carolina: A Novel Geospatial and Time Series Data AnalysisAmirreza Sahebi-Fakhrabad, Amir Hossein Sadeghi, Eda Kemahlioglu-Ziya, et al.
The American Journal of Hospice & Palliative Care|December 19, 2023
In-Hospital Code Status Updates: Trends Over Time and the Impact of COVID-19Amirreza Sahebi-Fakhrabad, Eda Kemahlioglu-Ziya, Robert Handfield, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
American Health & Drug Benefits|July 4, 2014
Insurance companies' perspectives on the orphan drug pipelineRobert Handfield, Josh Feldstein
Healthcare (Basel, Switzerland)|February 11, 2023
Evaluating State-Level Prescription Drug Monitoring Program (PDMP) and Pill Mill Effects on Opioid Consumption in Pharmaceutical Supply ChainAmirreza Sahebi-Fakhrabad, Amir Hossein Sadeghi, Robert Handfield
Healthcare (Basel, Switzerland)|July 13, 2024
Exploring Opioid Prescription Patterns and Overdose Rates in South Carolina (2017-2021): Insights into Rising Deaths in High-Risk AreasAmirreza Sahebi-Fakhrabad, Amir Hossein Sadeghi, Eda Kemahlioglu-Ziya, et al.
The Milbank Quarterly|November 2, 2020
A Commons for a Supply Chain in the Post-COVID-19 Era: The Case for a Reformed Strategic National StockpileRobert Handfield, Daniel Joseph Finkenstadt, Eugene S Schneller, et al.
Healthcare (Basel, Switzerland)|April 28, 2023
The Impact of Opioid Prescribing Limits on Drug Usage in South Carolina: A Novel Geospatial and Time Series Data AnalysisAmirreza Sahebi-Fakhrabad, Amir Hossein Sadeghi, Eda Kemahlioglu-Ziya, et al.
The American Journal of Hospice & Palliative Care|December 19, 2023
In-Hospital Code Status Updates: Trends Over Time and the Impact of COVID-19Amirreza Sahebi-Fakhrabad, Eda Kemahlioglu-Ziya, Robert Handfield, et al.
Pageof 1